MASSDEVICE ON CALL — San Diego-based NeuroVigil is launching its 1st clinical trials in Philadelphia, evaluating a new system that the company says can help patients suffering from ALS communicate and interact with the outside world.
The device maker has also launched a satellite office in Mountain View, Calif., where it’ll partner with NASA to further develop its brain-interface technology.